Response to Letter to the Editor From Boucai et al: "BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer"

J Clin Endocrinol Metab. 2022 Jun 16;107(7):e3103-e3104. doi: 10.1210/clinem/dgac135.

Author

Mingzhao Xing¹

Affiliation

¹ Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Papillary* / pathology
Humans
Lymphatic Metastasis
Proto-Oncogene Proteins B-raf / genetics
Thyroid Cancer, Papillary / pathology
Thyroid Neoplasms* / diagnosis
Thyroid Neoplasms* / pathology

Substances

BRAF protein, human
Proto-Oncogene Proteins B-raf